Loss of SOCS7 in mice results in severe cutaneous disease and increased mast cell activation

Clinical Immunology

Volumn 132, Issue 2, 2009, Pages 277-284

  Knisz, Judit ^a   Banks, Alex ^b   McKeag, Lisa ^a   Metcalfe, Dean D ^c   Rothman, Paul B ^a   Brown, Jared M ^d  

^a UNIVERSITY OF IOWA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Allergy; Atopic dermatitis; Mast cell; SOCS; Suppressor of cytokine signaling; TSLP

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR ALPHA; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 7; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BONE MARROW CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-13; INTERLEUKIN-6; MAST CELLS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN DISEASES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649970531     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.04.003     Document Type: Article

References (30)

1. Federici M., Giustizieri M.L., Scarponi C., Girolomoni G., and Albanesi C. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J. Immunol. 169 (2002) 434-442
2. Ekelund E., Saaf A., Tengvall-Linder M., Melen E., Link J., Barker J., Reynolds N.J., Meggitt S.J., Kere J., Wahlgren C.F., Pershagen G., Wickman M., Nordenskjold M., Kockum I., and Bradley M. Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis. Am. J. Hum. Genet. 78 (2006) 1060-1065
3. Knisz J., and Rothman P.B. Suppressor of cytokine signaling in allergic inflammation. J. Allergy Clin. Immunol. 119 (2007) 739-745
4. Brown J.M., Wilson T.M., and Metcalfe D.D. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 38 (2008) 4-18
5. Kirshenbaum A.S., Worobec A.S., Davis T.A., Goff J.P., Semere T., and Metcalfe D.D. Inhibition of human mast cell growth and differentiation by interferon gamma-1b. Exp. Hematol. 26 (1998) 245-251
6. Kulka M., and Metcalfe D.D. High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression. Blood 105 (2005) 592-599
7. Mann-Chandler M.N., Kashyap M., Wright H.V., Norozian F., Barnstein B.O., Gingras S., Parganas E., and Ryan J.J. IFN-gamma induces apoptosis in developing mast cells. J. Immunol. 175 (2005) 3000-3005
8. Starr R., Metcalf D., Elefanty A.G., Brysha M., Willson T.A., Nicola N.A., Hilton D.J., and Alexander W.S. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14395-14399
9. Banks A.S., Li J., McKeag L., Hribal M.L., Kashiwada M., Accili D., and Rothman P.B. Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J. Clin. Invest. 115 (2005) 2462-2471
10. Kremer B.E., Adang L.A., and Macara I.G. Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell 130 (2007) 837-850
11. Jensen B.M., Swindle E.J., Iwaki S., and Gilfillan A.M. Generation, isolation, and maintenance of rodent mast cells and mast cell lines. Curr. Protoc. Immunol. Chapter 3 (2006) Unit 3 23
12. Soule B.P., Brown J.M., Kushnir-Sukhov N.M., Simone N.L., Mitchell J.B., and Metcalfe D.D. Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J. Immunol. 179 (2007) 3276-3286
13. Palaniyandi S.S., Watanabe K., Ma M., Tachikawa H., Kodama M., and Aizawa Y. Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats. Eur. J. Immunol. 34 (2004) 3508-3515
14. Tkaczyk C., Metcalfe D.D., and Gilfillan A.M. Determination of protein phosphorylation in Fc epsilon RI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions. J. Immunol. Methods 268 (2002) 239-243
15. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J. Exp. Med. 203 (2006) 269-273
16. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., Smith K., Gorman D., Zurawski S., Abrams J., Menon S., McClanahan T., de Waal-Malefyt Rd R., Bazan F., Kastelein R.A., and Liu Y.J. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3 (2002) 673-680
17. Yoo J., Omori M., Gyarmati D., Zhou B., Aye T., Brewer A., Comeau M.R., Campbell D.J., and Ziegler S.F. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202 (2005) 541-549
18. Jessup H.K., Brewer A.W., Omori M., Rickel E.A., Budelsky A.L., Yoon B.R., Ziegler S.F., and Comeau M.R. Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. J. Immunol. 181 (2008) 4311-4319
19. Yamashita Y., Charles N., Furumoto Y., Odom S., Yamashita T., Gilfillan A.M., Constant S., Bower M.A., Ryan J.J., and Rivera J. Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J. Immunol. 179 (2007) 740-743
20. Levin S.D., Koelling R.M., Friend S.L., Isaksen D.E., Ziegler S.F., Perlmutter R.M., and Farr A.G. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J. Immunol. 162 (1999) 677-683
21. Pandey A., Ozaki K., Baumann H., Levin S.D., Puel A., Farr A.G., Ziegler S.F., Leonard W.J., and Lodish H.F. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 1 (2000) 59-64
22. Zhou B., Comeau M.R., De Smedt T., Liggitt H.D., Dahl M.E., Lewis D.B., Gyarmati D., Aye T., Campbell D.J., and Ziegler S.F. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6 (2005) 1047-1053
23. Al-Shami A., Spolski R., Kelly J., Keane-Myers A., and Leonard W.J. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 202 (2005) 829-839
24. Allakhverdi Z., Comeau M.R., Jessup H.K., Yoon B.R., Brewer A., Chartier S., Paquette N., Ziegler S.F., Sarfati M., and Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204 (2007) 253-258
25. Isaksen D.E., Baumann H., Trobridge P.A., Farr A.G., Levin S.D., and Ziegler S.F. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J. Immunol. 163 (1999) 5971-5977
26. Martens N., Uzan G., Wery M., Hooghe R., Hooghe-Peters E.L., and Gertler A. Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation. J. Biol. Chem. 280 (2005) 13817-13823
27. Kamura T., Sato S., Haque D., Liu L., and Kaelin W.G. Jr., R.C. Conaway, and J.W. Conaway, The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12 (1998) 3872-3881
28. Mooney R.A., Senn J., Cameron S., Inamdar N., Boivin L.M., Shang Y., and Furlanetto R.W. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem. 276 (2001) 25889-25893
29. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., and Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 (1997) 921-924
30. Rivera J., and Tessarollo L. Genetic background and the dilemma of translating mouse studies to humans. Immunity 28 (2008) 1-4